Wednesday, Oct 4, 2023 · SEC filings
What the smart money revealed on Oct 4
731 insider filings came in. We hid 96 planned (10b5-1) sellers and 507 people whose filings were routine, like grants and tax withholding.
Immunome (IMNM) President and CEO Clay Siegall bought $1M
169,204 shares on the open market. Not a grant or an option exercise. Their past buys: 2 of 6 checked quarters beat the typical stock 6 months later.
Overstock.com (NXH) Director Marcus Lemonis bought $493K
33,000 shares on the open market. Not a grant or an option exercise. Their past buys: 2 of 5 checked quarters beat the typical stock 6 months later.
Gaia (GAIA) Chairman Jirka Rysavy bought $270K
100,000 shares on the open market. Not a grant or an option exercise.
Immunome (IMNM) Chief Strategy Officer Bruce Turner bought $250K
42,300 shares on the open market. Not a grant or an option exercise.
Jabil (JBL) Executive Chairman Mark Mondello sold $7.65M
Not marked as a planned 10b5-1 sale. Sold 3% of the shares they held directly. Still holds 2.09M shares.
Monolithic Power Systems (MPWR) CEO Michael Hsing sold $5.02M
Not marked as a planned 10b5-1 sale. Sold 1% of the shares they held directly. Still holds 1M shares.
Jabil (JBL) Director Christopher Holland sold $2.08M
Not marked as a planned 10b5-1 sale. Sold 49% of the shares they held directly. Still holds 17,000 shares.
Show 16 more real buys
Show 74 more real sales
13F season
Holdings as of Sep 30, 2023 are due Nov 14
40 funds have filed so far. 40 filed for the quarter before.
Biggest real insider buys, Sep 28–Oct 4
Open-market buys by officers and directors, filed in the 7 days up to Oct 4.
Free weekly email
Each week's biggest real insider buys, cluster buys and fund moves, every one dated. One email a week. Unsubscribe in one click.